IP Library Granted Patent US 10,844,035
Granted Patent B2
US 10,844,035 · App. 16/034,876 · Granted Nov 24, 2020

Process for the production of cannabidiol and delta-9-tetrahydrocannabinol

Inventors: Lukas Dialer (Schaffhausen, CH); Denis Petrovic (Schaffhausen, CH); Ulrich Weigl (Schaffhausen, CH)
Assignee: PURISYS LLC
C07D311/78C07C37/11C07C37/14C07D205/04C07D311/04C07D311/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,844,035
App. No.
16/034,876
Granted
Nov 24, 2020
Kind
B2
Abstract

The present disclosure relates to a cannabidiol compound and compositions thereof and processes for preparing the compound and compositions. The processes include an acid-catalyzed reaction of a suitably selected and substituted di-bromo-olivetol or derivative thereof with a suitably selected and substituted cyclic alkene to produce a dibromo-cannabidiol compound or derivative thereof. The dibromo-cannabidiol compound or derivative thereof can be produced in high yield, high stereospecificity, or both. It can then be converted under reducing conditions to a cannabidiol compound or derivatives thereof.

Claims (15)

1. A process for the preparation of a composition comprising a compound of formula XVI:

or a pharmaceutically acceptable salt thereof;

said process comprising,

contacting compound XIV

wherein, X is Br;

with a reducing agent to prepare said composition, wherein said composition comprises at least 99.96 area % of the compound of formula XVI.

2. The process of claim 1 , wherein said composition is a white crystalline powder.

3. The process of claim 1 , wherein said reducing agent is sodium sulfite.

4. The process of claim 1 , further comprising:

contacting 4,6-dibromo-5-pentylbenzene-1,3-diol with menthadienol to prepare said compound of formula XIV, prior to said contacting compound XIV with said reducing agent.

5. The process of claim 4 , wherein said composition comprises less than 0.04 area % of 4-bromo-5-pentylbenzene-1,3-diol, 6-bromo-5-pentylbenzene-1,3-diol, and delta-9-tetrahydrocannabinol.

6. A process for the preparation of a compound of formula XIV:

or a pharmaceutically acceptable salt thereof;

said process comprising,

contacting 4,6-dibromo-5-pentylbenzene-1,3-diol or 4,6-dichloro-5-pentylbenzene-1,3-diol, with menthadienol in the presence of a protic or Lewis acid catalyst to prepare said compound of formula XIV.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded May 1, 2026
From: CERBERUS BUSINESS FINANCE, LLC
To: PURISYS LLC
Reel/Frame 074545/0764 →
ASSIGNMENT OF SECURITY INTEREST - PATENTS Recorded Mar 23, 2020
From: PURISYS LLC
To: CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 052207/0503 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2020
From: NORAMCO, LLC
To: PURISYS LLC
Reel/Frame 051433/0718 →
ENTITY CONVERSION Recorded Dec 31, 2019
From: NORAMCO, INC.
To: NORAMCO, LLC
Reel/Frame 051455/0724 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2018
From: DIALER, LUKAS; PETROVIC, DENIS; WEIGL, ULRICH
To: NORAMCO, INC.
Reel/Frame 046415/0203 →
Continuity (3)
Continuation 15199528 · Jun 30, 2016
Provisional Application 62191097 · Jul 10, 2015
Related Publication 20180319763A1 · Nov 8, 2018
Cited By (1)
US 12,252,477